Results 41 to 50 of about 2,340 (187)

Case Report: Management of Malignancy-Exacerbated Pemphigus Vulgaris During COVID-19 Pandemic

open access: yesFrontiers in Medicine, 2021
Pemphigus vulgaris is an intraepidermal autoimmune mucocutaneous blistering disease whose etiopathogenesis includes various trigger factors, i.e., drugs and malignancies.
Alberto Corrà   +16 more
doaj   +1 more source

Paraneoplastic Pemphigus: A Mini Review

open access: yes, 2022
Paraneoplastic pemphigus (PNP) is defined as an autoimmune, mucocutaneous, blistering disorder which is further associated with the development of lymphomas and other – mostly hematological- malignancies.
Andreadis Dimitrios   +2 more
core   +1 more source

Radiation-Associated Pemphigus Vulgaris in a Patient With Preceding Malignancy: Treatment With Rituximab as a Valuable Option

open access: yesFrontiers in Immunology, 2020
Pemphigus is a chronic autoimmune blistering disorder, characterized by (muco-)cutaneous erosions due to autoantibodies against desmoglein 3 and/or 1. Pemphigus induction might be associated with drugs, malignancy or radiation therapy (RT); the latter ...
Franziska Schauer   +6 more
doaj   +1 more source

Anaesthetic management of Castleman’s disease associated with paraneoplastic pemphigus: report of a rare case

open access: yesAin Shams Journal of Anesthesiology, 2019
Background Castleman’s disease is a rare lymphoproliferative disease which can mimic other malignant tumours and can be associated with paraneoplastic pemphigus especially in the paediatric age group.
Rajasree O.   +3 more
doaj   +1 more source

Paraneoplastic pemphigus. A trait d’union between dermatology and oncology [PDF]

open access: yes, 2015
Paraneoplastic pemphigus is a rare autoimmune disease of the skin associated with neoplasm. Nowadays, the pathogenesis of paraneoplastic pemphigus is not fully understood. Due to its rarity, various criteria have been proposed for the diagnosis. For this
Moliterni, Elisa   +6 more
core   +1 more source

Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease

open access: yesInternal Medicine Journal, EarlyView.
Abstract Idiopathic multicentric Castleman disease (iMCD) is a rare condition. The pathogenesis is incompletely understood; however, interleukin‐6 (IL‐6) is a major mediator. The clinical presentation is heterogeneous, from mild constitutional symptoms to severe multi‐organ failure.
Dipti Talaulikar   +16 more
wiley   +1 more source

ORAL PEMPHIGUS VULGARIS IN OLD WOMAN: CONDUCTS OF A CHALLENGING CASE

open access: yesRevista Naval de Odontologia On Line, 2021
Pemphigus is an autoimmune disease that, depending on the level of epithelial involvement, can be classified into pemphigus vulgaris, vegetans, erythematosus and foliaceus.
João Cesar Guimarães Henriques   +3 more
doaj   +1 more source

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda   +31 more
wiley   +1 more source

Paraneoplastic Pemphigus: A Case Report and Literature Review

open access: yes, 2013
Pemphigus is a bullous autoimmune disease of skin and mucous membrane that may be acute or chronic.There are two major types pemphigus vulgaris and pemphigus foliaceus.These two types are rare.A variant of pemhigus vulgaris is paraneoplastic pemphigus ...
Ajose, FA, Ademolu, AB, Lasisi, GT
core   +1 more source

Paraneoplastic Pemphigus in a 34-year-old [PDF]

open access: yes, 2017
Paraneoplastic Pemphigus (PNP) is a rare and often fatal autoimmune mucocutaneous blistering disease associated with an underlying malignancy. It is thought to be caused by antibodies to tumor antigenscross-reacting with epithelial antigens, specifically
Beasley, Jenna M   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy